Volpara takeover by Lunit gets tick from Grant Samuel

Volpara takeover by Lunit gets tick from Grant Samuel
A technician uses Volpara's system to screen for breast cancer. (Image: Getty)
Pattrick Smellie
Directors in Wellington-headquartered health-tech firm Volpara are recommending shareholders accept a 100% takeover bid from a Korean-listed counterpart after a favourable independent valuation.ASX-listed Volpara was judged by independent valuer Grant Samuel to be worth between A67c (72c) and A82c per share, compared with the takeover from Seoul-based Lunit pitched at A$1.15.The offer represented a 47% premium to the A87cps that Volpara was trading at before the Lunit bid on Dec 14, and 55% above the weighted average share price in the month be...

More Markets